Introduction: Fifty-three years after the first description of an inherited prothrombotic
condition (antithrombin deficiency), our knowledge on hereditary and acquired causes of …

Introduction Venous thromboembolism (VTE) is a complex disease that aggregates in
families. Both acquired and genetic risk factors are important. Proper recognition and …

Objectives Thrombin generation (TG) with and without thrombomodulin (TM) was evaluated
in COVID-19 patients with different disease severity and thromboprophylaxis regimen, in …

In recent years, the field of venous thromboembolism has undergone numerous innovations,
starting from the recent discoveries on the role of biomarkers, passing through the role of …

Background In this prospective cohort study, we aimed to evaluate the efficacy and safety of
direct oral anticoagulants (DOACs) versus heparin/vitamin K antagonists for the treatment of …

Snake venoms have evolved primarily to immobilize and kill prey, and consequently, they
contain some of the most potent natural toxins. Part of that armory is a range of hemotoxic …

High coagulation factor VIII (FVIII) levels comprise a common risk factor for venous
thromboembolism (VTE), but the underlying genetic determinants are largely unknown. We …

Introduction: The discovery of the factor V Leiden (FVL) missense mutation (Arg506Gln)
causing factor V resistance to the anticoagulant action of activated protein C was a landmark …

Venous thromboembolism (VTE) has a strong genetic component. This review summarizes
what is known at the seventeen genes that are now well established to harbour VTE …

Abstract Background & Aims The long‐term impact of sustained virological response (SVR)
after direct‐acting antivirals (DAA s) on the hypercoagulability associated with HCV cirrhosis …